Women taking popular weight-loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound had about a 30% lower risk of developing breast cancer in a large study of more than 110,000 patients. Credit: Shutterstock Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and manage diabetes. New research involving more than 110,000 women found that those taking GLP-1 drugs, a category that includes semaglutide-